Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research

Addressing the silent pandemic of antimicrobial resistance (AMR) is a focus of the 2021 G7 meeting. A major driver of AMR and poor clinical outcomes is suboptimal antimicrobial use. Current research in AMR is inequitably focused on new drug development. To achieve antimicrobial security we need to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Charani, Esmita, McKee, Martin, Ahmad, Raheelah, Balasegaram, Manica, Bonaconsa, Candice, Merrett, Gemma Buckland, Busse, Reinhard, Carter, Vanessa, Castro-Sanchez, Enrique, Franklin, Bryony D, Georgiou, Pantelis, Hill-Cawthorne, Kerri, Hope, William, Imanaka, Yuichi, Kambugu, Andrew, Leather, Andrew JM, Mbamalu, Oluchi, McLeod, M, Mendelson, Marc, Mpundu, Mirfin, Rawson, Timothy M, Ricciardi, Walter, Rodriguez-Manzano, Jesus, Singh, Sanjeev, Tsioutis, Constantinos, Uchea, Chibuzor, Zhu, Nina, Holmes, Alison H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454847/
https://www.ncbi.nlm.nih.gov/pubmed/34557847
http://dx.doi.org/10.1016/j.lanepe.2021.100161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454847/
https://www.ncbi.nlm.nih.gov/pubmed/34557847
http://dx.doi.org/10.1016/j.lanepe.2021.100161

Ejemplares similares